中国肿瘤临床
中國腫瘤臨床
중국종류림상
CHINESE JOURNAL OF CLINICAL ONCOLOGY
2013年
5期
271-274
,共4页
殷述刚%曹健鹏%黄梅%张秀军%李俊海
慇述剛%曹健鵬%黃梅%張秀軍%李俊海
은술강%조건붕%황매%장수군%리준해
上腔静脉滤器%上肢深静脉血栓形成%肺栓塞
上腔靜脈濾器%上肢深靜脈血栓形成%肺栓塞
상강정맥려기%상지심정맥혈전형성%폐전새
superior vena cava filter%upper extremity deep vein thrombosis%pulmonary embolism
目的:探讨应用上腔静脉滤器对肿瘤合并上肢深静脉血栓形成患者预防肺栓塞发生的安全性和有效性.方法:回顾性分析20例上肢深静脉血栓形成患者资料.20例患者中肺癌6例,胃癌4例,乳腺癌2例,卵巢癌、胰腺癌、鼻咽癌、白血病、恶性淋巴瘤、食管癌、贲门癌、胸腺瘤术后左颈部转移各1例.其中9例患者行PICC(Peripheral inserted central catheter)置管化疗,2例行锁骨下静脉置管化疗.结果:全部患者均成功置入上腔静脉滤器,保留深静脉置管的患者术后成功拔除深静脉导管,无手术相关并发症发生,随访6~24个月,术后无症状性肺栓塞、上腔静脉穿孔、滤器移位及上腔静脉综合征发生.结论:恶性肿瘤及深静脉置管是上肢深静脉血栓形成最重要的原因,上腔静脉滤器置入是预防肿瘤合并上肢深静脉血栓形成患者发生肺栓塞的一种安全和有效的措施.
目的:探討應用上腔靜脈濾器對腫瘤閤併上肢深靜脈血栓形成患者預防肺栓塞髮生的安全性和有效性.方法:迴顧性分析20例上肢深靜脈血栓形成患者資料.20例患者中肺癌6例,胃癌4例,乳腺癌2例,卵巢癌、胰腺癌、鼻嚥癌、白血病、噁性淋巴瘤、食管癌、賁門癌、胸腺瘤術後左頸部轉移各1例.其中9例患者行PICC(Peripheral inserted central catheter)置管化療,2例行鎖骨下靜脈置管化療.結果:全部患者均成功置入上腔靜脈濾器,保留深靜脈置管的患者術後成功拔除深靜脈導管,無手術相關併髮癥髮生,隨訪6~24箇月,術後無癥狀性肺栓塞、上腔靜脈穿孔、濾器移位及上腔靜脈綜閤徵髮生.結論:噁性腫瘤及深靜脈置管是上肢深靜脈血栓形成最重要的原因,上腔靜脈濾器置入是預防腫瘤閤併上肢深靜脈血栓形成患者髮生肺栓塞的一種安全和有效的措施.
목적:탐토응용상강정맥려기대종류합병상지심정맥혈전형성환자예방폐전새발생적안전성화유효성.방법:회고성분석20례상지심정맥혈전형성환자자료.20례환자중폐암6례,위암4례,유선암2례,란소암、이선암、비인암、백혈병、악성림파류、식관암、분문암、흉선류술후좌경부전이각1례.기중9례환자행PICC(Peripheral inserted central catheter)치관화료,2례행쇄골하정맥치관화료.결과:전부환자균성공치입상강정맥려기,보류심정맥치관적환자술후성공발제심정맥도관,무수술상관병발증발생,수방6~24개월,술후무증상성폐전새、상강정맥천공、려기이위급상강정맥종합정발생.결론:악성종류급심정맥치관시상지심정맥혈전형성최중요적원인,상강정맥려기치입시예방종류합병상지심정맥혈전형성환자발생폐전새적일충안전화유효적조시.
Objective:To discuss the safety and effectiveness of superior vena cava filter (SVCF) placement in cancer patients with upper extremity deep vein thrombosis (UEDVT). Methods:Retrospective analysis of the data from 20 cancer patients with UED-VT was conducted. Of the 20 patients, 6 had lung cancer, 4 had gastric cancer, and 2 had breast cancer. The remaining eight cases were ovarian cancer, pancreatic cancer, nasopharyngeal carcinoma, leukemia, malignant lymphoma, esophageal cancer, gastric cardia cancer, and metastasis to the neck after surgery for thymoma. Results:The SVCF was successfully implanted in all patients. The deep-vein catheter was successfully removed from the patients who underwent deep venous catheterization without surgical complications. Com-plications such as post-operative asymptomatic pulmonary embolism, filter migration, and superior vena cava syndrome did not occur in any of the cases within the 6 months to 24 months of follow up. Conclusion:Malignant tumors and deep venous catheterization are the most important causes of UEDVT. SVCF placement is safe and effective in preventing pulmonary embolism in the cancer patients with UEDVT.